List of Tables
Table 1. Cannabinoid Derived Pharmaceutical Market Trends
Table 2. Cannabinoid Derived Pharmaceutical Market Drivers & Opportunity
Table 3. Cannabinoid Derived Pharmaceutical Market Challenges
Table 4. Cannabinoid Derived Pharmaceutical Market Restraints
Table 5. Global Cannabinoid Derived Pharmaceutical Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cannabinoid Derived Pharmaceutical Revenue Market Share by Company (2019-2024)
Table 7. Global Cannabinoid Derived Pharmaceutical Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Cannabinoid Derived Pharmaceutical Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Cannabinoid Derived Pharmaceutical Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Cannabinoid Derived Pharmaceutical Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Cannabinoid Derived Pharmaceutical Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Cannabinoid Derived Pharmaceutical
Table 13. Global Cannabinoid Derived Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabinoid Derived Pharmaceutical as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cannabinoid Derived Pharmaceutical Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cannabinoid Derived Pharmaceutical Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Cannabinoid Derived Pharmaceutical Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Cannabinoid Derived Pharmaceutical Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Cannabinoid Derived Pharmaceutical Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Cannabinoid Derived Pharmaceutical Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Cannabinoid Derived Pharmaceutical Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Cannabinoid Derived Pharmaceutical Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Cannabinoid Derived Pharmaceutical Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Cannabinoid Derived Pharmaceutical Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Cannabinoid Derived Pharmaceutical Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Cannabinoid Derived Pharmaceutical Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Cannabinoid Derived Pharmaceutical Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Cannabinoid Derived Pharmaceutical Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Cannabinoid Derived Pharmaceutical Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Cannabinoid Derived Pharmaceutical Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Cannabinoid Derived Pharmaceutical Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Cannabinoid Derived Pharmaceutical Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Cannabinoid Derived Pharmaceutical Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Cannabinoid Derived Pharmaceutical Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Cannabinoid Derived Pharmaceutical Sales Value by Region (2019-2024) & (%)
Table 44. Global Cannabinoid Derived Pharmaceutical Sales Value by Region (2025-2030) & (%)
Table 45. Global Cannabinoid Derived Pharmaceutical Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Cannabinoid Derived Pharmaceutical Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Cannabinoid Derived Pharmaceutical Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Cannabinoid Derived Pharmaceutical Sales Volume by Region (2019-2024) & (%)
Table 49. Global Cannabinoid Derived Pharmaceutical Sales Volume by Region (2025-2030) & (%)
Table 50. Global Cannabinoid Derived Pharmaceutical Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Cannabinoid Derived Pharmaceutical Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Cannabinoid Derived Pharmaceutical Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Cannabinoid Derived Pharmaceutical Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Cannabinoid Derived Pharmaceutical Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Cannabinoid Derived Pharmaceutical Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Cannabinoid Derived Pharmaceutical Sales Volume, (2025-2030) & (K Units)
Table 57. Cara Therapeutics Inc Company Information
Table 58. Cara Therapeutics Inc Introduction and Business Overview
Table 59. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Cara Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Offerings
Table 61. Cara Therapeutics Inc Recent Development
Table 62. Arena Pharmaceuticals Company Information
Table 63. Arena Pharmaceuticals Introduction and Business Overview
Table 64. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Arena Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Offerings
Table 66. Arena Pharmaceuticals Recent Development
Table 67. Cannabics Pharmaceuticals Inc Company Information
Table 68. Cannabics Pharmaceuticals Inc Introduction and Business Overview
Table 69. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Cannabics Pharmaceuticals Inc Cannabinoid Derived Pharmaceutical Product Offerings
Table 71. Cannabics Pharmaceuticals Inc Recent Development
Table 72. Echo Pharmaceuticals Company Information
Table 73. Echo Pharmaceuticals Introduction and Business Overview
Table 74. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Echo Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Offerings
Table 76. Echo Pharmaceuticals Recent Development
Table 77. Gw Pharmaceuticals Company Information
Table 78. Gw Pharmaceuticals Introduction and Business Overview
Table 79. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Gw Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Offerings
Table 81. Gw Pharmaceuticals Recent Development
Table 82. Inmed Pharmaceuticals Company Information
Table 83. Inmed Pharmaceuticals Introduction and Business Overview
Table 84. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Inmed Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Offerings
Table 86. Inmed Pharmaceuticals Recent Development
Table 87. Insys Therapeutics Inc Company Information
Table 88. Insys Therapeutics Inc Introduction and Business Overview
Table 89. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Insys Therapeutics Inc Cannabinoid Derived Pharmaceutical Product Offerings
Table 91. Insys Therapeutics Inc Recent Development
Table 92. Larapharm Company Information
Table 93. Larapharm Introduction and Business Overview
Table 94. Larapharm Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Larapharm Cannabinoid Derived Pharmaceutical Product Offerings
Table 96. Larapharm Recent Development
Table 97. Mgc Pharmaceuticals Ltd Company Information
Table 98. Mgc Pharmaceuticals Ltd Introduction and Business Overview
Table 99. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Mgc Pharmaceuticals Ltd Cannabinoid Derived Pharmaceutical Product Offerings
Table 101. Mgc Pharmaceuticals Ltd Recent Development
Table 102. One World Cannabis Company Information
Table 103. One World Cannabis Introduction and Business Overview
Table 104. One World Cannabis Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. One World Cannabis Cannabinoid Derived Pharmaceutical Product Offerings
Table 106. One World Cannabis Recent Development
Table 107. Orpheus Medica Company Information
Table 108. Orpheus Medica Introduction and Business Overview
Table 109. Orpheus Medica Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Orpheus Medica Cannabinoid Derived Pharmaceutical Product Offerings
Table 111. Orpheus Medica Recent Development
Table 112. Receptor Life Sciences Company Information
Table 113. Receptor Life Sciences Introduction and Business Overview
Table 114. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Receptor Life Sciences Cannabinoid Derived Pharmaceutical Product Offerings
Table 116. Receptor Life Sciences Recent Development
Table 117. Respirerx Pharmaceuticals Company Information
Table 118. Respirerx Pharmaceuticals Introduction and Business Overview
Table 119. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Respirerx Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Offerings
Table 121. Respirerx Pharmaceuticals Recent Development
Table 122. Tetra Bio-Pharma Company Information
Table 123. Tetra Bio-Pharma Introduction and Business Overview
Table 124. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Tetra Bio-Pharma Cannabinoid Derived Pharmaceutical Product Offerings
Table 126. Tetra Bio-Pharma Recent Development
Table 127. Cardiol Therapeutics Company Information
Table 128. Cardiol Therapeutics Introduction and Business Overview
Table 129. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Cardiol Therapeutics Cannabinoid Derived Pharmaceutical Product Offerings
Table 131. Cardiol Therapeutics Recent Development
Table 132. United Cannabis Corporation Company Information
Table 133. United Cannabis Corporation Introduction and Business Overview
Table 134. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. United Cannabis Corporation Cannabinoid Derived Pharmaceutical Product Offerings
Table 136. United Cannabis Corporation Recent Development
Table 137. Zynerba Pharmaceuticals Company Information
Table 138. Zynerba Pharmaceuticals Introduction and Business Overview
Table 139. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Zynerba Pharmaceuticals Cannabinoid Derived Pharmaceutical Product Offerings
Table 141. Zynerba Pharmaceuticals Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Cannabinoid Derived Pharmaceutical Downstream Customers
Table 145. Cannabinoid Derived Pharmaceutical Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Cannabinoid Derived Pharmaceutical Product Picture
Figure 2. Global Cannabinoid Derived Pharmaceutical Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cannabinoid Derived Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Cannabinoid Derived Pharmaceutical Sales Volume (2019-2030) & (K Units)
Figure 5. Global Cannabinoid Derived Pharmaceutical Sales Price (2019-2030) & (US$/Unit)
Figure 6. Cannabinoid Derived Pharmaceutical Report Years Considered
Figure 7. Global Cannabinoid Derived Pharmaceutical Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Cannabinoid Derived Pharmaceutical Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cannabinoid Derived Pharmaceutical Revenue in 2023
Figure 10. Cannabinoid Derived Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Cannabinoid Receptor Type 1 (CB1) Picture
Figure 12. Cannabinoid Receptor Type 2 (CB2) Picture
Figure 13. Others Picture
Figure 14. Global Cannabinoid Derived Pharmaceutical Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Cannabinoid Derived Pharmaceutical Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Cannabinoid Derived Pharmaceutical Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Cannabinoid Derived Pharmaceutical Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Cannabinoid Derived Pharmaceutical Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Epilepsy
Figure 20. Product Picture of Migraine
Figure 21. Product Picture of Multiple Sclerosis
Figure 22. Product Picture of Others
Figure 23. Global Cannabinoid Derived Pharmaceutical Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Cannabinoid Derived Pharmaceutical Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Cannabinoid Derived Pharmaceutical Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Cannabinoid Derived Pharmaceutical Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Cannabinoid Derived Pharmaceutical Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Cannabinoid Derived Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Cannabinoid Derived Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Cannabinoid Derived Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Cannabinoid Derived Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Cannabinoid Derived Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Cannabinoid Derived Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Cannabinoid Derived Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Cannabinoid Derived Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Cannabinoid Derived Pharmaceutical Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Cannabinoid Derived Pharmaceutical Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Cannabinoid Derived Pharmaceutical Sales Volume (%), (2019-2030)
Figure 40. United States Cannabinoid Derived Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Cannabinoid Derived Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Cannabinoid Derived Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Cannabinoid Derived Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Cannabinoid Derived Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Cannabinoid Derived Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 46. China Cannabinoid Derived Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Cannabinoid Derived Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 48. China Cannabinoid Derived Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Cannabinoid Derived Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Cannabinoid Derived Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Cannabinoid Derived Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Cannabinoid Derived Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Cannabinoid Derived Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Cannabinoid Derived Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Cannabinoid Derived Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Cannabinoid Derived Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Cannabinoid Derived Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 58. India Cannabinoid Derived Pharmaceutical Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Cannabinoid Derived Pharmaceutical Sales Value by Type (%), 2023 VS 2030
Figure 60. India Cannabinoid Derived Pharmaceutical Sales Value by Application (%), 2023 VS 2030
Figure 61. Cannabinoid Derived Pharmaceutical Industrial Chain
Figure 62. Cannabinoid Derived Pharmaceutical Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
